BioSpace News Archive

Drug Development

British Journal of Psychiatry Publishes Results from Phase 3 Study of Alexza Pharmaceuticals, Inc.'s AZ-004 for the Treatment of Agitation in Patients with Schizophrenia

January 24, 2011
·
6 min read
Policy

PharmAthene, Inc. Provides Update on Litigation With SIGA Technologies, Inc.

January 24, 2011
·
2 min read
American Scientific Resources Inc. Listing Upgrade to the OTCQB Market

January 24, 2011
·
2 min read
Business

NxStage Medical, Inc. Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein

January 24, 2011
·
3 min read
Policy

Optimer Pharmaceuticals, Inc. Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)

January 24, 2011
·
6 min read
Business

Weikang Bio-Technology Group Co., Inc. Announces Fourth Quarter Revenue Contribution from Newest Sales Agents

January 24, 2011
·
3 min read
Pharm Country

NPS Pharmaceuticals, Inc. Back from the Brink

January 24, 2011
·
1 min read
Business

BioMarin Pharmaceutical Inc. to Host Fourth Quarter and Full Year 2010 Financial Results

January 24, 2011
·
2 min read
National Institutes of Health (NIH): Federal Research Center Will Help Develop Medicines

January 24, 2011
·
1 min read
Biotech Beach

Genesis Biopharma, Inc. Expresses Support for FDA Codevelopment Guidelines

January 24, 2011
·
2 min read